You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multidisciplinary tumor board

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Best Practice
  • +6 more
  • (no location specified)
Jul 12, 2022

Cancer Trial in Lexington (Therapeutic Intervention)

Recruiting
  • Cancer
  • Therapeutic Intervention
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Nov 18, 2022

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +3 more
  • Virtual centralized multidisciplinary tumour board
  • (no location specified)
Apr 15, 2021

Generating Novel Therapeutic Strategies Based on Evolutionary

Recruiting
  • Incurable Disease
  • Evolutionary Tumor Board (ETB)
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2022

Cancer Trial (Treatment recommendations made by Molecular Tumor Board.)

Not yet recruiting
  • Cancer
  • Treatment recommendations made by Molecular Tumor Board.
  • (no location specified)
Aug 9, 2022

Cancer, Severe Major Depression, Schizophrenia Trial (Virtual Cancer and Mental Health Tumor Board)

Not yet recruiting
  • Cancer
  • +8 more
  • Virtual Cancer and Mental Health Tumor Board
  • (no location specified)
Apr 26, 2023

Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))

Recruiting
  • Hematologic Neoplasms
  • Solid Neoplasm
  • PMMTB (Precision Medicine Molecular Tumor Board)
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 7, 2022

Sarcoma Trial in Rome

Recruiting
  • Sarcoma
    • Rome, Italy
      "Regina Elena" National Cancer Institute
    Oct 6, 2023

    NSCLC Trial in Lexington (Molecular tumor board assisted care)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Molecular tumor board assisted care
    • Lexington, Kentucky
      University of Kentucky
    Apr 13, 2022

    Solid Tumor, Lymphoma Trial in Lyon (Multidisciplinary day hospitalization)

    Recruiting
    • Solid Tumor
    • Lymphoma
    • Multidisciplinary day hospitalization
    • Lyon, France
      Centre Leon Berard
    May 11, 2023

    Oesophageal Cancer, Gastric Cancer Trial in Dublin (Multidisciplinary rehabilitation programme delivered via telehealth)

    Completed
    • Oesophageal Cancer
    • Gastric Cancer
    • Multidisciplinary rehabilitation programme delivered via telehealth
    • Dublin, Leinster, Ireland
      Trinity College Dublin
    Apr 5, 2022

    Breast Cancer, Germ Cell Tumor Trial in Brussels (Ergospirometry)

    Not yet recruiting
    • Breast Cancer
    • Germ Cell Tumor
    • Ergospirometry
    • (no location specified)
    Aug 12, 2022

    Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

    Recruiting
    • Cancer
    • +2 more
    • Cellworks Report
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 20, 2023

    Physician and Molecular Tumor Board Perspectives on Clinical

    Recruiting
    • Pan-cancer
    • Cellworks Singula and Ventura reports
    • Sioux Falls, South Dakota
      Avera McKennan
    Apr 1, 2022

    Glioma Trial in United States

    Recruiting
    • Glioma
      • Basking Ridge, New Jersey
      • +6 more
      Aug 3, 2022

      Frailty Trial in Palo Alto, Nashville, Houston (PAUSE Intervention)

      Enrolling by invitation
      • Frailty
      • PAUSE Intervention
      • Palo Alto, California
      • +2 more
      Nov 2, 2021

      Immunotherapy in Locally Advanced or Oligometastatic NSCLC

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • induction therapy
      • Esslingen, Germany
        Klinikum Esslingen
      Aug 15, 2022

      Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment

      Recruiting
      • Medulloblastoma
      • +2 more
      • Specialized Tumor Board Treatment Plan
      • San Diego, California
      • +3 more
      Dec 28, 2022

      Soft Tissue Sarcoma Trial in France (drug, combination product, other)

      Recruiting
      • Soft Tissue Sarcoma
      • Bordeaux, France
      • +17 more
      Oct 4, 2022

      The Voice asTool to Detect Recurrence of Laryngeal and

      Not yet recruiting
      • Laryngeal Cancer
      • Hypopharyngeal Cancer
      • Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
      • Bern, Switzerland
        Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
      May 30, 2023

      Recurrent High Grade Glioma Trial (Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
      • (no location specified)
      Jul 21, 2022

      Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +11 more
      • KEYTRUDA®
      • (no location specified)
      Nov 17, 2023

      ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • NGS and ctDNA-MRD detection
      • Changsha, Hunan, China
        Department of Thoracic Surgery, Second Xiangya Hospital of Centr
      Apr 18, 2023

      Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)

      Not yet recruiting
      • Glioblastoma
      • 18F-GE-180 PET
      • +4 more
      • Rozzano, (mi), Italy
        IRCCS Istituto Clinico Humanitas
      Oct 27, 2023

      Chemoresistance Mechanisms in Pancreatic Cancer

      Not yet recruiting
      • Patients With Non-metastatic Pancreatic Cancer
      • Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
      • ctDNA detection
      • Shanghai, Shanghai, China
        Zhongshan Hospital
      Apr 27, 2023